ZTS
Zoetis Inc - Class A
DRUG MANUFACTURERS - SPECIALTY & GENERIC · HEALTHCARE
Zoetis Inc. (ZTS) stands as a premier global leader in animal health, focusing on the innovation and manufacturing of pharmaceuticals and vaccines for livestock and companion animals alike. Leveraging a robust portfolio backed by advanced research, Zoetis addresses the critical demands of animal agr...
$80.05
+0.43% (+$0.34)
Volume
8.56M
52W High
$172.23
52W Low
$72.38
Market Cap
$37.70B
Next Earnings Report
Last Reported
May 7, 2026 Missed
Actual: $1.53
vs. Consensus: $1.57
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 7, 2026
1-Day:
-5.13%
5-Day:
-11.88%
Q1 2026
Apr 30, 2026
1-Day:
-0.70%
5-Day:
-2.11%
Q4 2025
Feb 12, 2026
1-Day:
+0.80%
5-Day:
-0.06%
Q3 2025
Nov 4, 2025
1-Day:
-3.19%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $2.26B | +1.9% | 71.7% | 36.3% | $601.0M |
| Q4'25 | $2.39B | +3.0% | 68.9% | 34.6% | $603.0M |
| Q3'25 | $2.40B | +0.5% | 70.2% | 39.0% | $721.0M |
| Q2'25 | $2.46B | +4.2% | 72.3% | 40.2% | $718.0M |
| Q1'25 | $2.22B | +1.4% | 70.5% | 38.1% | $631.0M |
| Q4'24 | $2.32B | +4.7% | 68.0% | 33.0% | $581.0M |
| Q3'24 | $2.39B | +11.0% | 69.2% | 38.5% | $682.0M |
| Q2'24 | $2.36B | +8.3% | 70.2% | 38.4% | $624.0M |
Company Information
Symbol
ZTS
Company
Zoetis Inc - Class A
Market Cap
$37.70B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - SPECIALTY & GENERIC
Compare ZTS with competitors
Side-by-side earnings comparison